Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1124377]Researchers: Prof Peter Gibbs (Principal investigator) , Prof Bert Vogelstein
Brief description The management of patients after surgery for rectal cancer presents multilpe dilemmas; what treatment should be given and to which patients? Our initial studies in colorectal cancer patients demonstrate that a novel blood biomarker (circulating tumour DNA) can accurately predict patient risk of recurrence and with serial samples, can indicate whether chemotherapy is being effective. During follow-up changes in this biomarker promise to be a specific and very early indicator of cancer recurrence.
Funding Amount $AUD 1,350,907.62
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1124377
- PURL : https://purl.org/au-research/grants/nhmrc/1124377